Here are what the editors at HealthDay consider to be the most important developments in Urology for September 2009. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Efficacy of Treatments for Overactive Bladder Examined
WEDNESDAY, Sept. 30 (HealthDay News) -- Sacral nerve stimulation and botulinum toxin are effective treatments for overactive bladder, according to two studies in the October issue of the Journal of Urology.
Abstract - White
Full Text (subscription or payment may be required)
Abstract - Giannantoni
Full Text (subscription or payment may be required)
More Research Finds Limited Benefit From PSA Test
WEDNESDAY, Sept. 30 (HealthDay News) -- Men should be aware of their chances of benefits and harms from prostate-specific antigen (PSA) testing before the test, but many are not discussing screening before making the decision, according to the results of two studies in the Sept. 28 Archives of Internal Medicine.
Abstract - Howard
Full Text (subscription or payment may be required)
Abstract - Hoffman
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Editorial (subscription or payment may be required)
Bacterial Infections Are a Factor in Many H1N1 Deaths
WEDNESDAY, Sept. 30 (HealthDay News) -- Many patients who have died of H1N1 influenza this year had a bacterial co-infection that likely contributed to their deaths, according to a Sept. 29 early release of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.
Full Text
Bladder Cancer Surgery Delay Linked to Poorer Survival
WEDNESDAY, Sept. 30 (HealthDay News) -- In patients with bladder cancer, less delay between transurethral tumor resection and cystectomy may improve the chances of survival, particularly in those with lower stage disease, according to research published in the October issue of the Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Biopsy Protocols Compared for Prostate Cancer Detection
TUESDAY, Sept. 29 (HealthDay News) -- Twelve-core and eight-core biopsies have similar prostate cancer detection rates for initial biopsy, but the additional transition cores provided in 12-core biopsy may be helpful in detecting missed cancers in repeat biopsies, according to a study in the October issue of the Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Editorial
Recurrence of Frank Hematuria Requires Careful Assessment
MONDAY, Sept. 28 (HealthDay News) -- In patients who have an initial episode of frank hematuria without a diagnosis, followed by a later recurrence, thorough evaluation is necessary due to a substantial risk of urological cancer, according to research published in the October issue of the Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
H1N1 Virus's Genetic Makeup Appears to Be Staying Stable
MONDAY, Sept. 28 (HealthDay News) -- The genetic makeup of the H1N1 flu has remained stable, which means the yet-to-be-released vaccine is likely to be a good match for the virus, the U.S. Centers for Disease Control and Prevention announced at a Sept. 25 media briefing.
More Information
Childhood Nephrotic Syndrome Can Cause Lifelong Ills
FRIDAY, Sept. 25 (HealthDay News) -- Children with minimal-change nephrotic syndrome are at increased risk for osteoporosis, hypertension, sperm abnormalities and cataracts if the condition persists beyond puberty, according to a study published online Sept. 24 in the Clinical Journal of the American Society of Nephrology.
Abstract
Full Text (subscription or payment may be required)
Study Casts Further Doubt on PSA for Cancer Screening
FRIDAY, Sept. 25 (HealthDay News) -- Based on likelihood ratios, prostate specific antigen (PSA) concentrations at any cutoff value didn't meet the criteria needed for a screening test, according to research published online Sept. 24 in BMJ.
Abstract
Full Text
Editorial (subscription or payment may be required)
Analysis (subscription or payment may be required)
New Paradigm for Progress in Surgery Proposed
FRIDAY, Sept. 25 (HealthDay News) -- In a series of articles in the Sept. 26 issue of The Lancet, a cohort of surgical-thought leaders proposes a new paradigm for innovation, research, and evidence-based advancement in the field of surgery.
Abstract - Barkun
Full Text (subscription or payment may be required)
Abstract - Ergina
Full Text (subscription or payment may be required)
Abstract - McCulloch
Full Text (subscription or payment may be required)
More Information
Alcohol Found to Lessen Risk for Enlarged Prostate
THURSDAY, Sept. 24 (HealthDay News) -- A man's risk of developing benign prostatic hyperplasia (BHP) decreases as his consumption of alcohol increases, but not the risk of lower urinary tract symptoms (LUTS), according to a meta-analysis reported in the October issue of the Journal of Urology.
Abstract
Full Text (subscription or payment may be required)
Widowhood Affects Sexual Infection Risk in Older Men
WEDNESDAY, Sept. 23 (HealthDay News) -- Older men may have an increased risk of sexually transmitted infections after losing a spouse, especially if they take medications for erectile dysfunction, according to a study published online Sept. 17 in the American Journal of Public Health.
Abstract
Full Text (subscription or payment may be required)
Review Advises Hand Washing, Other Antiviral Measures
WEDNESDAY, Sept. 23 (HealthDay News) -- Hand washing, wearing a mask, and isolating potential cases are all effective in interrupting the spread of viral respiratory infections and should be given greater attention when planning for widespread outbreaks, according to research published Sept. 22 in BMJ.
Abstract
Full Text
Spotlight on Social Networking Use Among Medical Students
TUESDAY, Sept. 22 (HealthDay News) -- A majority of medical schools report instances of medical students posting unprofessional content on social networking Web sites, including some instances of violations of patient confidentiality, according to a report in the Sept. 23/30 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Physician Medical Errors Linked to Fatigue and Burnout
TUESDAY, Sept. 22 (HealthDay News) -- The incidence of medical error is associated with a host of factors related to physician fatigue, burnout, and mental and emotional well-being, according to a study in the Sept. 23/30 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Taxes on Sugared Sodas Could Cut Consumption
WEDNESDAY, Sept. 16 (HealthDay News) -- Imposing a tax on sugar-sweetened beverages could reduce consumption and generate income for obesity reduction and healthy eating education interventions, according to an article published online Sept. 16 in the New England Journal of Medicine.
Full Text
Hispanic/Latino Community Has Unique Cancer Profile
WEDNESDAY, Sept. 16 (HealthDay News) -- Hispanics and Latinos have a unique cancer profile that means they are less likely to get the four most common cancers, but are more likely to develop cancers related to infection, according to a report published Sept. 15 by the American Cancer Society.
More Information
Report
FDA Approves Four Vaccines for H1N1 Influenza
TUESDAY, Sept. 15 (HealthDay News) -- The U.S. Food and Drug Administration has approved four H1N1 influenza vaccines, according to a Sept. 15 news release issued by the agency.
More Information
Conservative Management in Prostate Cancer Feasible
TUESDAY, Sept. 15 (HealthDay News) -- In older men with localized prostate cancer, conservative management is associated with significantly improved 10-year outcomes compared to earlier eras, according to a study published in the Sept. 16 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Drug Interaction E-Alerts Show Benefit to Patient Safety
MONDAY, Sept. 14 (HealthDay News) -- Drug interaction alerts from electronic prescribing likely improve patient safety and reduce costs in outpatient care, despite the fact that over 90 percent of the alerts are overridden by physicians, according to a study in the Sept. 14 issue of Archives of Internal Medicine.
Abstract
Full Text
New Prostate Stem Cell May Be a Source of Cancer
MONDAY, Sept. 14 (HealthDay News) -- A new type of prostate stem cell isolated from adult mice may be a source of prostate cancer, according to a study published online Sept. 9 in Nature.
Abstract
Full Text (subscription or payment may be required)
Mutated H1N1 Virus Resistant to Antiviral Drug Oseltamivir
FRIDAY, Sept. 11 (HealthDay News) -- The discovery of H1N1 mutations resistant to the neuraminidase inhibitor oseltamivir in two adolescent girls sharing a cabin at a North Carolina camp prompted a new recommendation from the U.S. Centers for Disease Control and Prevention on the proper prophylactic use of antiviral drugs, according to a case report in the Sept. 11 issue of the CDC's Morbidity and Mortality Weekly Report.
Full Text
Prostate Cancer Patients Seek Several Information Sources
FRIDAY, Sept. 4 (HealthDay News) -- Between diagnosis of local stage prostate cancer and treatment, men access an average of five information sources, according to a study published in the September issue of Urology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Study Supports MRI Use for Renal Lesions in Pregnancy
FRIDAY, Sept. 4 (HealthDay News) -- Magnetic resonance imaging (MRI) is acceptable imaging to be performed in women with renal lesions incidentally detected during routine antenatal ultrasonography, according to a study in the September issue of Urology.
Abstract
Full Text (subscription or payment may be required)
Diabetes Control Can Increase Men's Testosterone Levels
THURSDAY, Sept. 3 (HealthDay News) -- In men with type 2 diabetes who have erectile dysfunction, better glycemic control may significantly increase serum testosterone levels, according to a study published in the September issue of Urology.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Findings Support Deferred Prostate Cancer Treatment
THURSDAY, Sept. 3 (HealthDay News) -- Some men with prostate cancer may safely defer treatment for years without a higher risk of metastasis or cancer mortality than those who receive initial treatment, according to research published online Aug. 31 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Editorial
Diagnoses, Health Costs Rise in Partners of Cancer Patients
THURSDAY, Sept. 3 (HealthDay News) -- Health care use increases in partners of cancer patients following the cancer diagnosis, according to research published online Aug. 31 in the Journal of Clinical Oncology.
Abstract
Full Text (subscription or payment may be required)
Body Mass, Weight Gain Linked to Prostate Cancer Risk
WEDNESDAY, Sept. 2 (HealthDay News) -- Men's body mass, as well as weight gain in adulthood, may affect their risk of prostate cancer, according to research published online Sept. 1 in Cancer Epidemiology, Biomarkers & Prevention.
Abstract
Full Text (subscription or payment may be required)
Academic Medical Centers Active and Diverse in Research
TUESDAY, Sept. 1 (HealthDay News) -- Research at academic medical centers is active and diverse, with nearly a quarter of life-science researchers receiving no funding, and relationships with industry more commonly seen among translational and clinical researchers than basic science researchers, according to a study in the Sept. 2 issue of the Journal of the American Medical Association.
Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Prostate-Specific Antigen Test May Increase Overdiagnosis
TUESDAY, Sept. 1 (HealthDay News) -- Since the prostate-specific antigen (PSA) test was introduced, many men have been overdiagnosed with prostate cancer, according to a study published online Aug. 31 in the Journal of the National Cancer Institute.
Abstract
Full Text (subscription or payment may be required)
Editorial
